Summary

Eligibility
for people ages 65 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Dates
study started
estimated completion
Principal Investigator
by Deborah Barnes, PhD
Headshot of Deborah Barnes
Deborah Barnes

Description

Summary

The eRADAR Brain Health Study seeks to refine and test a novel, low-cost strategy for increasing dementia detection within primary care.

Official Title

Low-cost Detection of Dementia Using Electronic Health Records Data: Validation and Testing of the eRADAR Algorithm in a Pragmatic, Patient-centered Trial.

Details

eRADAR stands for "electronic health record (EHR) Risk of Alzheimer's and Dementia Assessment Rule." It is a low-cost tool or algorithm that uses readily available EHR data elements to identify high-risk patients. We will conduct a pragmatic randomized controlled trial to assess the impact of implementing eRADAR as part of a supported outreach process on dementia detection rates. We will also explore the impact of eRADAR implementation on healthcare utilization and patient experience.

Keywords

Dementia Alzheimer Disease Brain Health Assessment

Eligibility

You can join if…

Open to people ages 65 years and up

  • No prior diagnosis of dementia (defined from EHR diagnosis codes) and not receiving medications for dementia
  • Active patient at participating clinic
  • Adequate data to calculate eRADAR score

You CAN'T join if...

  • Currently receiving hospice care

Lead Scientist at UCSF

  • Deborah Barnes, PhD
    Dementia prevalence is expected to triple worldwide over the next 40 years at tremendous monetary and emotional cost.

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Kaiser Permanente
ID
NCT05356702
Study Type
Interventional
Participants
Expecting 4050 study participants
Last Updated